Get started
Author

Milena Tumelero

Observed names: M. Tumelero, Milena tumelero, Tumelero, Milena
ORCID: 0009-0000-6999-6019
Observed ORCID: 0009-0000-6999-6019
OpenAlex ID: A5117242282
Neoadjuvant immune checkpoint inhibitors for localized dMMR/MSI-H gastric cancer: a meta-analysis
2026 · W.K. Schwengber, R.A. Pereira, et al. · ESMO Open · 4
Evolving treatment strategies for EGFRex20ins-mutated NSCLC: a comprehensive review of Amivantamab’s role and future directions
2025 · Rafael Alvim Pereira, Milena Tumelero, et al. · ecancermedicalscience · 2
PDF
Central Nervous System as a Sanctuary for Advanced Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer
2025 · Gabriel Lenz, Rafael Alvim Pereira, et al. · touchREVIEWS in Oncology & Haematology · 2
PDF
Complications of Temporary Transvenous Cardiac Pacing by Access Site: A Systematic Review and Meta‐Analysis
2026 · Rafael Alvim Pereira, Gabriel Barcellos, et al. · Pacing and Clinical Electrophysiology · 1
PDF
Molecular subtypes and lymph-node metastasis in endometrial cancer: An updated systematic review and meta-analysis
2026 · Rafael Alvim Pereira, Gabriel Barcellos, et al. · Surgical Oncology
Impact of Concomitant Statin Use on Survival Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2026 · Rafael Alvim Pereira, Pedro Figueiroa, et al. · Asian Pacific Journal of Cancer Nursing
PDF
Molecular subtypes and lymph-node metastasis in endometrial cancer: An updated systematic review and meta-analysis.
2026 · Rafael Alvim Pereira, Gabriel Barcellos Andrade Camargo, et al. · Journal of Clinical Oncology
KRAS Inhibition in Non-Small Cell Lung Cancer with Central Nervous System Involvement: Current Evidence and Future Directions
2026 · Rafael Alvim Pereira, Christian Oliveira, et al. · Oncology Research and Treatment
Neoadjuvant immune checkpoint inhibitors (ICIs) for localized dMMR/MSI-h gastroesophageal cancers (GEC): A systematic review with meta-analysis.
2026 · Wallace Klein Schwengber, Rafael Alvim Pereira, et al. · Journal of Clinical Oncology
The Impact of Corticosteroid Use on the Efficacy and Safety of Checkpoint Inhibitors Across Cancer Types
2026 · Rafael Alvim Pereira, Milena Tumelero, et al. · touchREVIEWS in Oncology & Haematology
PDF
Premature Deaths and Life-Years Lost From Lack of Amivantamab in Brazil's Unified Health System
2025 · Gabriel Lenz, Rafael Alvim Pereira, et al. · JCO Global Oncology
PDF
1863P Low versus standard-dose anti-PD1 immunotherapy for NSCLC: A Kaplan-Meier reconstructed individual-patient data meta-analysis
2025 · W. Klein Schwengber, I. Michellon, et al. · Annals of Oncology
Osteoporose Secundária Ao Uso De Corticoides No Tratamento De Doenças Autoimunes
2024 · Tumelero, Milena, Brustolin Xavier, Paula · Seminário de Iniciação Científica e Seminário Integrado de Ensino, Pesquisa e Extensão (SIEPE)
PDF
Opções Terapêuticas Na Osteoporose Induzida Por Corticoides
2024 · Milena tumelero, PAULA BRUSTOLIN XAVIER · Congresso Brasileiro de Doenças Crônicas
PDF
O Impacto Da Síndrome De Down No Contexto Familiar
2023 · Tumelero, Milena, Casani, Lainá, et al. · Seminário de Iniciação Científica e Seminário Integrado de Ensino, Pesquisa e Extensão (SIEPE)
PDF
Works count: 16
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type